Overview

Tantalizing Therapeutics in Bronchopulmonary Dysplasia is a concise reference that provides an overview of emerging concepts in the understanding of lung development and injury from a molecular and cellular point-of-view, including exciting pathways that are paving the way for new options to prevent or treat Bronchopulmonary Dysplasia (BPD). The book's chapters are written by experts who are at the forefront of BPD research. Coverage includes chapters on exosomes, stem cells and miRs, as well as a section on new discoveries in BPD research with translational potential. This is a must-have reference for researchers, physicians and trainees working on BPD, lung developmental biology, and more.

Full Product Details

Author:   Vineet Bhandari (Department of Pediatrics (Neonatology), The Children’s Regional Hospital at Cooper/Cooper Medical School of Rowan University, Camden, NJ) ,  Vineet Bhandari (Department of Pediatrics, Drexel University College of Medicine, Philadelphia, PA, USA) ,  Vineet Bhandari (Department of Pediatrics, Drexel University College of Medicine, Philadelphia, PA, USA) ,  Vineet Bhandari (Department of Pediatrics, Drexel University College of Medicine, Philadelphia, PA, USA)
Publisher:   Elsevier Science Publishing Co Inc
Imprint:   Academic Press Inc
Weight:   0.410kg
ISBN:  

9780128189870

ISBN 10:   0128189878
Pages:   288
Publication Date:   03 June 2020
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Paperback
Publisher's Status:   Active
Availability:   Manufactured on demand  
We will order this item for you from a manufactured on demand supplier.

Table of Contents

Section 1: Current Therapeutics: State of the Art 1. Systemic and topical glucocorticoids to prevent BPD Kristi Watterberg and Olivier Baud 2. Use of caffeine for prevention of BPD Abhay Lodha, Stefani Doucette, and Vineet Bhandari 3. Next Generation ventilator strategies to prevent/manage BPD Martin Keszler and Ashish Gupta Section 2: Ongoing Therapeutic Studies with Translational Potential 4. End points for therapeutic trials for BPD: lessons learned from clinical trials Judy L. Aschner and Cynthia T. McEvoy 5. What can exogenous surfactant provide in the fight against BPD? Peter A. Dargaville 6. Stem cells in the treatment of BPD So Yoon Ahn, Yun Sil Chang, Won Soon Park Section 3: Future Therapeutic Directions 7. Extracellular vesicles in the therapy of BPD Flore Lesage and Bernard Thebaud 8. Growth factors in the therapy of BPD Heber C. Nielsen, Anne Chetty, and Vineet Bhandari 9. Antenatal approaches in the therapy of BPD Andre Gie, Ignacio Valenzuela, Thomas Salaets, Jan Deprest, and Jaan Toelen 10. miRs –mere hype or master regulators in the therapy of BPD? Charitharth Vivek Lal, Vivek Shukla, Namasivayam Ambalavanan, and Vineet Bhandari 11. Immune modulators for the therapy of BPD Margaret Gilfillan and Vineet Bhandari

Reviews

Author Information

Dr. Bhandari is the Division Head of Neonatology at The Children’s Regional Hospital at Cooper/Cooper Medical School of Rowan University, Camden, NJ. He previously served as a Professor in the Department of Pediatrics at Drexel University College of Medicine, Philadelphia, PA and an Associate Professor of Pediatrics and Obstetrics, Gynecology and Reproductive Sciences at Yale University School of Medicine, New Haven, CT. Dr. Bhandari has been awarded three patents, with a fourth pending. He is an Associate Editor of Pediatric Research, BMC Pediatrics, Frontiers in Pediatrics and Internet Journal of Medical Update. He is on the editorial board of Journal of Perinatology. He has also served as Guest Editor, Managing Editor and Contributing Editor of several other publications. He is a manuscript reviewer for almost 100 research publications and has published over 290 peer-reviewed articles and chapters in books.

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions